The activation of the FGF19/FGFR4 signaling pathway increases the infiltration of TAMs and myeloid-derived suppressor cells (MDSCs) while decreasing the accumulation of CD8+ T cells, leading to the formation of an immunosuppressive microenvironment that favors tumor progression 154. The gene discussed is FGFR4; the disease is neoplasm.